Cellebrite DI
Cellebrite DI Ltd. develops software and services for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company provides a platform of software solutions used to access, collect, review, extract, decode, decrypt, analyze, share and manage digital evidence across the investigative lifecycle for a range of investigations, such as child exp… Read more
Cellebrite DI (CLBT) - Total Liabilities
Latest total liabilities as of December 2025: $454.53 Million USD
Based on the latest financial reports, Cellebrite DI (CLBT) has total liabilities worth $454.53 Million USD as of December 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Cellebrite DI - Total Liabilities Trend (2019–2025)
This chart illustrates how Cellebrite DI's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Cellebrite DI Competitors by Total Liabilities
The table below lists competitors of Cellebrite DI ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Apar Industries Limited
NSE:APARINDS
|
India | ₹64.60 Billion |
|
Indian Railway Catering And Tourism Corporation Limited
NSE:IRCTC
|
India | ₹33.71 Billion |
|
Dongfang Electric Corporation Limited
PINK:DNGFF
|
USA | $117.23 Billion |
|
Gongniu Group Co Ltd
SHG:603195
|
China | CN¥5.60 Billion |
|
Jiangsu King's Luck Brewery Joint-Stock Co Ltd
SHG:603369
|
China | CN¥7.97 Billion |
|
Beijing Dabeinong Technology Group Co Ltd
SHE:002385
|
China | CN¥19.27 Billion |
|
YTL Power International Bhd
KLSE:6742
|
Malaysia | RM50.91 Billion |
Liability Composition Analysis (2019–2025)
This chart breaks down Cellebrite DI's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.56 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.94 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.48 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Cellebrite DI's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Cellebrite DI (2019–2025)
The table below shows the annual total liabilities of Cellebrite DI from 2019 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $454.53 Million | +28.20% |
| 2024-12-31 | $354.55 Million | -28.90% |
| 2023-12-31 | $498.67 Million | +51.38% |
| 2022-12-31 | $329.43 Million | -20.26% |
| 2021-12-31 | $413.13 Million | +37.44% |
| 2020-12-31 | $300.58 Million | +35.76% |
| 2019-12-31 | $221.41 Million | -- |